Skip to main content

Ana Villa María

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Ana Villa María

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Juan A. Porcel Vázquez

Juan A. Porcel Vázquez

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Joaquim Cahors Gomez

Joaquim Cahors Gomez

Gestió i Administració
Purchase and Biddings Unit
Finance Directorate
Read more
Victor Franco Puntes

Victor Franco Puntes

Head of group
Pharmacokinetic Nanoparticles
Read more
Francisco Javier Medel Rebollo

Francisco Javier Medel Rebollo

Main researcher
Clinical Pharmacology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.